Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Interleukin- 21
Most Correlated Studies
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- CD8+ T cells activated by antigen; effects of gamma-cytokine treatment
Most Relevant Literature
- The role of Interleukin-21 (IL-21) in allergic disorders: Biological insights and regulatory mechani…
- Biological effects of IL-21 on immune cells and its potential for cancer treatment.
- T-cell help in the germinal center: homing in on the role of IL-21.
- A structural blueprint for interleukin-21 signal modulation.
- Cut-off values for IL-21 and IL-23 as biochemical markers for pemphigus vulgaris.
Most Relevant Clinical Trials
- Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction.
- Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer
- Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer
- Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma
- Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recur…
